Cabaletta Bio (CABA) was upgraded to Zacks Rank #2 (Buy), signaling improving earnings expectations. The note is constructive for sentiment and could support the shares in the near term, but it does not include any new operating data or guidance.
Cabaletta Bio (CABA) was upgraded to Zacks Rank #2 (Buy), signaling improving earnings expectations. The note is constructive for sentiment and could support the shares in the near term, but it does not include any new operating data or guidance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
